Compare AVTR & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | GKOS |
|---|---|---|
| Founded | 1904 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.6B |
| IPO Year | 2019 | 2015 |
| Metric | AVTR | GKOS |
|---|---|---|
| Price | $7.72 | $103.21 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | $12.89 | ★ $133.07 |
| AVG Volume (30 Days) | ★ 8.9M | 661.0K |
| Earning Date | 04-24-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,552,200,000.00 | $507,442,000.00 |
| Revenue This Year | $1.10 | $23.39 |
| Revenue Next Year | $1.90 | $27.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $7.58 | $73.16 |
| 52 Week High | $16.79 | $130.23 |
| Indicator | AVTR | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 26.17 | 40.57 |
| Support Level | N/A | $81.54 |
| Resistance Level | $14.29 | $103.63 |
| Average True Range (ATR) | 0.33 | 3.85 |
| MACD | 0.00 | -1.19 |
| Stochastic Oscillator | 9.59 | 28.90 |
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.